Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Langenfeld, Elaine ^a   Hong, Charles C ^b   Lanke, Gandhi ^a   Langenfeld, John ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 1 ANTAGONIST; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; CYTOKINE RECEPTOR; DMH2; PROTEIN ALK2; PROTEIN LD1; PROTEIN LD2; PROTEIN LD3; RECEPTOR BLOCKING AGENT; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CLONOGENESIS; CONTROLLED STUDY; GENE SILENCING; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; LUNG CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL;

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BRONCHI; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CLONE CELLS; ENDOTHELIAL CELLS; EPITHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; LUNG NEOPLASMS; PYRAZOLES; PYRIMIDINES; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84876081183     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061256     Document Type: Article

References (61)

1. Nickel J, Sebald W, Groppe JC, Mueller TD, (2009) Intricacies of BMP receptor assembly. Cytokine Growth Factor Rev 20: 367-377.
2. Lavery K, Swain P, Falb D, Alaoui-Ismaili MH, (2008) BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. J Biol Chem 283: 20948-20958.
3. Attisano L, Wrana JL, (2002) Signal transduction by the TGF-beta superfamily. Science 296: 1646-1647.
4. Pizette S, Abate-Shen C, Niswander L, (2001) BMP controls proximodistal outgrowth, via induction of the apical ectodermal ridge, and dorsoventral patterning in the vertebrate limb. Development 128: 4463-4474.
5. Yang X, Castilla LH, Xu X, Li C, Gotay J, et al. (1999) Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 126: 1571-1580.
6. Chang H, Huylebroeck D, Verschueren K, Guo Q, Matzuk MM, et al. (1999) Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 126: 1631-1642.
7. Ying QL, Nichols J, Chambers I, Smith A, (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281-292.
8. Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, et al. (2003) The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24: 1445-1454. Epub 2003 Jun 1419.
9. Langenfeld EM, Bojnowski J, Perone J, Langenfeld J, (2005) Expression of bone morphogenetic proteins in human lung carcinomas. Ann Thorac Surg 80: 1028-1032.
10. Le Page C, Puiffe ML, Meunier L, Zietarska M, de Ladurantaye M, et al. (2009) BMP-2 signaling in ovarian cancer and its association with poor prognosis. J Ovarian Res 2: 4.
11. Yuen HF, Chan YP, Cheung WL, Wong YC, Wang X, et al. (2008) The prognostic significance of BMP-6 signaling in prostate cancer. Mod Pathol 21: 1436-1443. Epub 2008 Oct 1417.
12. Park Y, Kang MH, Seo HY, Park JM, Choi CW, et al. (1192) Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression. Med Oncol 27: 1192-1199.
13. Langenfeld EM, Langenfeld J, (2004) Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2: 141-149.
14. Raida M, Clement JH, Leek RD, Ameri K, Bicknell R, et al. (2005) Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 131: 741-750. Epub 2005 Nov 2001.
15. Rothhammer T, Bataille F, Spruss T, Eissner G, Bosserhoff AK (2007) Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene 26: 4158-4170. Epub 2006 Dec 4118.
16. Langenfeld EM, Kong Y, Langenfed J (2005) Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene Epub.
17. Alani RM, Young AZ, Shifflett CB (2001) Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc Natl Acad Sci U S A 98: 7812-7816. Epub 2001 Jun 7826.
18. Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, et al. (2007) ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A 104: 19506-19511.
19. Swarbrick A, Roy E, Allen T, Bishop JM (2008) Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proc Natl Acad Sci U S A 105: 5402-5407. Epub 2008 Mar 5431.
20. Ling MT, Wang X, Zhang X, Wong YC, (2006) The multiple roles of Id-1 in cancer progression. Differentiation 74: 481-487.
21. Swarbrick A, Akerfeldt MC, Lee CS, Sergio CM, Caldon CE, et al. (2005) Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1. Oncogene 24: 381-389.
22. Li B, Tsao SW, Li YY, Wang X, Ling MT, et al. (2009) Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int J Cancer 125: 2576-2585.
23. Rothschild SI, Kappeler A, Ratschiller D, Betticher DC, Tschan MP,et al. The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer. Lung 71: 306-311. Epub 2010 Aug 2014.
24. Rollin J, Blechet C, Regina S, Tenenhaus A, Guyetant S, et al. (2009) The intracellular localization of ID2 expression has a predictive value in non small cell lung cancer. PLoS One 4: e4158. Epub 2009 Jan 4158.
25. Ponz-Sarvise M, Nguewa PA, Pajares MJ, Agorreta J, Lozano MD,et al. Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance. Clin 17: 4155-4166. Epub 2011 May 4153.
26. Hao J, Ho JN, Lewis JA, Karim KA, Daniels RN,et al. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol 5: 245-253.
27. Leite M, Quinta-Costa M, Leite PS, Guimaraes JE, (1999) Critical evaluation of techniques to detect and measure cell death-study in a model of UV radiation of the leukaemic cell line HL60. Anal Cell Pathol 19: 139-151.
28. Sountoulidis A, Stavropoulos A, Giaglis S, Apostolou E, Monteiro R, et al. (2012) Activation of the Canonical Bone Morphogenetic Protein (BMP) Pathway during Lung Morphogenesis and Adult Lung Tissue Repair. PLoS One 7: e41460. Epub 42012 Aug 41420.
29. Rosendahl A, Pardali E, Speletas M, Ten Dijke P, Heldin CH, et al. (2002) Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation. Am J Respir Cell Mol Biol 27: 160-169.
30. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, et al. (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64: 9027-9034.
31. Ke Y, Reddel RR, Gerwin BI, Miyashita M, McMenamin M, et al. (1988) Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation 38: 60-66.
32. Kiesslich T, Berr F, Alinger B, Kemmerling R, Pichler M,et al. Current Status of Therapeutic Targeting of Developmental Signalling Pathways in Oncology. Curr Pharm Biotechnol 2011: 24.
33. Ye L, Mason MD, Jiang WG Bone morphogenetic protein and bone metastasis, implication and therapeutic potential. Front 16: 865-897.
34. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, et al. (2002) The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277: 5330-5338. Epub 2001 Nov 5319.
35. Lawson KA, Dunn NR, Roelen BA, Zeinstra LM, Davis AM, et al. (1999) Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev 13: 424-436.
36. Kishimoto Y, Lee KH, Zon L, Hammerschmidt M, Schulte-Merker S, (1997) The molecular nature of zebrafish swirl: BMP2 function is essential during early dorsoventral patterning. Development 124: 4457-4466.
37. Tada A, Nishihara T, Kato H, (1998) Bone morphogenetic protein 2 suppresses the transformed phenotype and restores actin microfilaments of human lung carcinoma A549 cells. Oncol Rep 5: 1137-1140.
38. Soda H, Raymond E, Sharma S, Lawrence R, Cerna C, et al. (1998) Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units. Anticancer Drugs 9: 327-331.
39. Beck SE, Jung BH, Del Rosario E, Gomez J, Carethers JM, (2007) BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK. Cell Signal 19: 1465-1472.
40. Miyazaki H, Watabe T, Kitamura T, Miyazono K, (2004) BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells. Oncogene 23: 9326-9335.
41. Langenfeld EM, Kong Y, Langenfeld J, (2006) Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene 25: 685-692.
42. Shepherd TG, Theriault BL, Nachtigal MW (2008) Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells. Gene 414: 95-105. Epub 2008 Mar 2004.
43. Gray MJ, Dallas NA, Van Buren G, Xia L, Yang AD, et al. (2008) Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver. Oncogene 27: 7192-7200. Epub 2008 Sep 7122.
44. Chen SS, Claus R, Lucas DM, Yu L, Qian J,et al. Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood 117: 862-871. Epub 2010 Nov 2022.
45. Noetzel E, Veeck J, Horn F, Hartmann A, Knuchel R, et al. (2008) [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer]. Pathologe 29: 319-327.
46. Umetani N, Mori T, Koyanagi K, Shinozaki M, Kim J, et al. (2005) Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Oncogene 24: 4721-4727.
47. Zhang J, Li L, (2005) BMP signaling and stem cell regulation. Dev Biol 284: 1-11.
48. Izumi M, Fujio Y, Kunisada K, Negoro S, Tone E, et al. (2001) Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway. J Biol Chem 276: 31133-31141.
49. Sugimori K, Matsui K, Motomura H, Tokoro T, Wang J, et al. (2005) BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. J Bone Miner Metab 23: 411-419.
50. Raida M, Clement JH, Ameri K, Han C, Leek RD, et al. (2005) Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death. Int J Oncol 26: 1465-1470.
51. Mern DS, Hasskarl J, Burwinkel B (2010) Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells. Br J Cancer 103: 1237-1244. Epub 2010 Sep 1214.
52. Mern DS, Hoppe-Seyler K, Hoppe-Seyler F, Hasskarl J, Burwinkel B (2010) Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells. Breast Cancer Res Treat 124: 623-633. Epub 2010 Feb 2027.
53. Lin J, Guan Z, Wang C, Feng L, Zheng Y, et al. (2010) Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res 16: 77-87. Epub 2009 Dec 2022.
54. Okada H, Mak TW, (2004) Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 4: 592-603.
55. Zou H, Wieser R, Massague J, Niswander L, (1997) Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes Dev 11: 2191-2203.
56. Korchynskyi O, ten Dijke P, (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277: 4883-4891.
57. Ke Y, Reddel RR, Gerwin BI, Miyashita M, McMenamin M, et al. (1988) Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation 38: 60-66.
58. Langenfeld EM, Kong Y, Langenfeld J, (2005) Bone morphogenetic protein-2-induced transformation involves the activation of mammalian target of rapamycin. Mol Cancer Res 3: 679-684.
59. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, et al. (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4: 33-41. Epub 2007 Nov 2018.
60. Hao J, Daleo MA, Murphy CK, Yu PB, Ho JN, et al. (2008) Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One 3: e2904.
61. Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, et al. (2008) BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med 14: 1363-1369. Epub 2008 Nov 1330.